Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Plos One
|
July 24, 2008
Type I interferon: potential therapeutic target for psoriasis?
Yihong Yao, Laura Richman, Chris Morehouse, et al.
Pigment Cell & Melanoma Research
|
December 3, 2013
MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D
Robert W Georgantas, Katie Streicher, Xiaobing Luo, et al.
Arthritis and Rheumatism
|
May 30, 2009
Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus
Yihong Yao, Laura Richman, Brandon W Higgs, et al.
BMC Medical Genomics
|
November 23, 2012
Genomic signatures characterize leukocyte infiltration in myositis muscles
Wei Zhu, Katie Streicher, Nan Shen, et al.
Annals of the Rheumatic Diseases
|
August 2, 2011
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
Brandon W Higgs, Zheng Liu, Barbara White, et al.
Plos One
|
November 3, 2011
Altered expression of insulin receptor isoforms in breast cancer
Jiaqi Huang, Chris Morehouse, Katie Streicher, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 24, 2014
Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies
Robert W Georgantas, Katie Streicher, Steven A Greenberg, et al.
Annals of the Rheumatic Diseases
|
July 30, 2011
Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study
Joan T Merrill, Daniel J Wallace, Michelle Petri, et al.
Annals of the Rheumatic Diseases
|
February 26, 2013
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
Brandon W Higgs, Wei Zhu, Chris Morehouse, et al.
Human Gene Therapy
|
August 27, 2020
Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology
Juliette Hordeaux, Elizabeth L Buza, Cecilia Dyer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Plos One
|
July 24, 2008
Type I interferon: potential therapeutic target for psoriasis?
Yihong Yao, Laura Richman, Chris Morehouse, et al.
Pigment Cell & Melanoma Research
|
December 3, 2013
MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D
Robert W Georgantas, Katie Streicher, Xiaobing Luo, et al.
Arthritis and Rheumatism
|
May 30, 2009
Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus
Yihong Yao, Laura Richman, Brandon W Higgs, et al.
BMC Medical Genomics
|
November 23, 2012
Genomic signatures characterize leukocyte infiltration in myositis muscles
Wei Zhu, Katie Streicher, Nan Shen, et al.
Annals of the Rheumatic Diseases
|
August 2, 2011
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
Brandon W Higgs, Zheng Liu, Barbara White, et al.
Plos One
|
November 3, 2011
Altered expression of insulin receptor isoforms in breast cancer
Jiaqi Huang, Chris Morehouse, Katie Streicher, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 24, 2014
Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies
Robert W Georgantas, Katie Streicher, Steven A Greenberg, et al.
Annals of the Rheumatic Diseases
|
July 30, 2011
Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study
Joan T Merrill, Daniel J Wallace, Michelle Petri, et al.
Annals of the Rheumatic Diseases
|
February 26, 2013
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
Brandon W Higgs, Wei Zhu, Chris Morehouse, et al.
Human Gene Therapy
|
August 27, 2020
Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology
Juliette Hordeaux, Elizabeth L Buza, Cecilia Dyer, et al.
Page
of 3